Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus associated with immune dysregulation. The use of immunosuppressant drugs as part of COVID-19 treatment (such as Tocilizumab or high -dose corticosteroids) increases the risk of opportunistic infections. Here we present a case of a patient without prior immunosuppression that developed a serious fungal infection after the use of high dose corticosteroids in the setting of severe COVID-19 and cryptogenic organizing pneumonia.
All Keywords
【저자키워드】 COVID-19, Corticosteroids, Cryptococcus neoformans, 【초록키워드】 Corticosteroid, Treatment, SARS-CoV-2, High dose, severe COVID-19, Immunosuppression, risk, drug, coronavirus 2, Novel coronavirus, Patient, respiratory, opportunistic Infections, Organizing pneumonia, Fungal infection, immune dysregulation, increase, 【제목키워드】 Infection, Cryptococcus,
【저자키워드】 COVID-19, Corticosteroids, Cryptococcus neoformans, 【초록키워드】 Corticosteroid, Treatment, SARS-CoV-2, High dose, severe COVID-19, Immunosuppression, risk, drug, coronavirus 2, Novel coronavirus, Patient, respiratory, opportunistic Infections, Organizing pneumonia, Fungal infection, immune dysregulation, increase, 【제목키워드】 Infection, Cryptococcus,